Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF - Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $10.29 and traded as high as $11.70. Ono Pharmaceutical shares last traded at $11.70, with a volume of 3,098 shares traded.
Ono Pharmaceutical Stock Up 0.9 %
The firm has a market capitalization of $5.55 billion, a P/E ratio of 11.36 and a beta of 0.57. The firm's fifty day moving average price is $10.41 and its 200-day moving average price is $11.09. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.55 and a quick ratio of 2.80.
Ono Pharmaceutical (OTCMKTS:OPHLF - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $0.21 earnings per share (EPS) for the quarter. Ono Pharmaceutical had a return on equity of 9.10% and a net margin of 15.15%.
About Ono Pharmaceutical
(
Get Free Report)
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Recommended Stories
Before you consider Ono Pharmaceutical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.
While Ono Pharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
